Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Complete remissions in non small cell lung cancer


We studied 241 patients with non small cell bronchogenic cancer who were treated with cisplatin and etoposide or cisplatin, etoposide and vindesine. There were 11 (4.5%) complete responders in these series most of whom had a prolonged survival.

This is a preview of subscription content, log in to check access.


  1. 1.

    Aisner J, Hansen H H: Current status of chemotherapy for non small cell lung cancer.Cancer Treat Rep 65, 979 (1981).

  2. 2.

    Gralla R J, Casper E S, Kelsen D Tet al: Cisplatin and vindesine combination chemotherapy for advance carcinoma of the lung: a randomized trial investigating two dosage schedules.Ann Intern Med 95, 414 (1981).

  3. 3.

    Longeval E, Klastersky J and the E.O.R.T.C. Lung Cancer Working Party Belgium: Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma.Cancer 50, 2751 (1982).

  4. 4.

    Klastersky J, Sculier J P, Nicaise Cet al: Combination chemotherapy with cisplatin, etoposide and vindesine in non small cell lung carcinoma: a clinical trial of the EORTC Lung Cancer Working Party.Cancer Treat Rep 67, 727 (1983).

  5. 5.

    WHO-EORTC-NCI Meeting for Standardization of Results of Cancer Treatment (Brussels, 1979); published by WHO.

  6. 6.

    Casper E S, Gralla R J, Kelsen D P, Golbey R B: Complete responses of non small cell lung carcinoma to combination chemotherapy. In:Abstracts of the Third World Conference on Lung Cancer, May, 1982.

Download references

Author information

Correspondence to J. Klastersky.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Klastersky, J., Sculier, J.P. & Mommen, P. Complete remissions in non small cell lung cancer. Med. Oncol. & Tumor Pharmacother. 2, 11–15 (1985).

Download citation

Key words

  • Complete remission
  • Lung cancer
  • Non small cell carcinoma